![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/01/2906367/0/en/Addex-Shareholders-Approve-All-Resolutions-at-Annual-General-Meeting.html
https://www.globenewswire.com/news-release/2024/06/06/2894387/0/en/Addex-Therapeutics-Reports-Q1-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/06/05/2893551/0/en/Addex-Convenes-Annual-General-Meeting-2024.html
https://www.globenewswire.com/news-release/2024/05/31/2891253/0/en/Addex-Therapeutics-to-Release-Q1-2024-Financial-Results-and-Host-Conference-Call-on-June-6-2024.html
https://www.globenewswire.com/news-release/2024/04/29/2870890/0/en/Addex-Provides-Update-on-ADX71149-Phase-2-Epilepsy-Study.html
https://www.fiercebiotech.com/biotech/janssen-partnered-epilepsy-drug-fails-phase-2-trial-latest-bad-luck-addex
https://www.globenewswire.com/news-release/2024/04/19/2865937/0/en/Addex-to-Present-at-the-Swiss-Biotech-Day-2024.html
https://www.globenewswire.com/news-release/2024/04/18/2865088/0/en/Addex-Therapeutics-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/11/2861223/0/en/Addex-Therapeutics-to-Release-Full-Year-2023-Financial-Results-and-Host-Conference-Call-on-April-18-2024.html
https://www.globenewswire.com//news-release/2024/03/14/2845974/0/en/Addex-to-Present-at-the-Bio-Europe-Spring-2024-Conference.html